Compare STOK & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | PSIX |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2019 | N/A |
| Metric | STOK | PSIX |
|---|---|---|
| Price | $31.96 | $62.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $33.11 | ★ $98.76 |
| AVG Volume (30 Days) | ★ 895.6K | 422.4K |
| Earning Date | 11-04-2025 | 02-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.27 |
| EPS | 0.68 | ★ 5.26 |
| Revenue | $205,632,000.00 | ★ $675,481,000.00 |
| Revenue This Year | $430.24 | $50.35 |
| Revenue Next Year | N/A | $20.10 |
| P/E Ratio | $46.62 | ★ $12.45 |
| Revenue Growth | ★ 1128.17 | 54.78 |
| 52 Week Low | $5.35 | $18.10 |
| 52 Week High | $38.69 | $121.78 |
| Indicator | STOK | PSIX |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 46.37 |
| Support Level | $31.50 | $61.86 |
| Resistance Level | $33.90 | $69.90 |
| Average True Range (ATR) | 2.10 | 3.80 |
| MACD | -0.22 | 0.68 |
| Stochastic Oscillator | 34.13 | 32.70 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.